Your session is about to expire
← Back to Search
Smoking Cessation Therapies for Quitting Smoking in People With HIV (SMARTTT Trial)
SMARTTT Trial Summary
This trial will test different ways to help people with HIV quit smoking.
SMARTTT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSMARTTT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SMARTTT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.You smoke at least five cigarettes a day.I am 18 years old or older.You smoke regularly, either every day or some days.You have smoked at least 100 cigarettes during your lifetime.I do not have any severe or unstable health conditions.I have used nicotine replacement, varenicline, or bupropion in the last week.I am HIV positive.
- Group 1: 12 wks NRT/ 12 wks VAR or bupropion
- Group 2: 12 wks NRT/ 12 wks NRT+CM
- Group 3: 12 wks NRT+CM / 12 wks NRT+CM
- Group 4: 12 wks NRT+CM/12 wks NRT+CM plus
- Group 5: 12 wks NRT/ 12 wks NRT
- Group 6: 12 wks NRT+CM/ 12 wks VAR or bupropion+CM
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cohort size of this trial?
"Affirmative. Clinicaltrials.gov documents show that the clinical trial, which was first announced on July 27th 2020, is now seeking participants. 632 patients must be enlisted from three distinct research facilities."
What maladies has Contingency Management been successful in mitigating?
"Contingency Management is a viable approach for treating attention deficit hyperactivity disorder (ADHD). Other conditions such as seasonal affective disorder, nicotine addiction and smoking cessation may also be managed using this technique."
How efficacious is Contingency Management for patient health and wellbeing?
"The safety of Contingency Management has been substantiated by Phase 4 trials, thus earning a score of 3 out of the possible range."
Is registration still open for the participants of this trial?
"Affirmative. The particulars of this medical trial, which was first released on July 27th 2020, is currently being updated on clinicaltrials.gov and searching for 632 participants from 3 different sites."
What prior examinations have been conducted to assess the efficacy of Contingency Management?
"Contingency Management has a long history, having been initially researched by The University of Hong Kong in 2006. Since then 754 trials have concluded with an additional 113 presently underway; many of which are taking place within New Haven, Connecticut."
Share this study with friends
Copy Link
Messenger